Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,507 | -11,771 | -8,709 | -12,372 | -1,111 |
| Depreciation Amortization | 2,905 | 5 | 2,479 | 132 | 2 |
| Accounts receivable | N/A | N/A | 1 | 32 | N/A |
| Other Working Capital | -748 | 273 | 763 | -388 | 361 |
| Other Operating Activity | 123 | 750 | 1,072 | 8,579 | 71 |
| Operating Cash Flow | $-18,227 | $-10,742 | $-4,395 | $-4,016 | $-677 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,630 | -12,979 | N/A | N/A | N/A |
| PPE Investments | -4 | -13 | -3 | 1,387 | N/A |
| Investing Cash Flow | $4,626 | $-12,992 | $-3 | $1,387 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,662 | N/A | 149 | N/A |
| Debt Repayment | N/A | -1,873 | N/A | N/A | N/A |
| Common Stock Issued | 31,237 | 24,056 | 2,117 | 465 | N/A |
| Other Financing Activity | 7,797 | 13,960 | 18 | 5,331 | 0 |
| Financing Cash Flow | $39,033 | $37,805 | $2,135 | $5,945 | $N/A |
| Exchange Rate Effect | 543 | 851 | -5 | -1 | -14 |
| Beginning Cash Position | 16,105 | 1,425 | 3,747 | 573 | 739 |
| End Cash Position | 42,080 | 16,347 | 1,480 | 3,887 | 49 |
| Net Cash Flow | $25,975 | $14,922 | $-2,267 | $3,314 | $-690 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,227 | -10,742 | -4,395 | -4,016 | -677 |
| Capital Expenditure | -4 | -13 | -3 | -6 | N/A |
| Free Cash Flow | -18,231 | -10,756 | -4,397 | -4,022 | -677 |